- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 11.02. | PL BioScience Wins Regulatory Certification from Japan's PMDA | ||
| 11.02. | FUJIFILM Biotechnologies Expands in the UK | ||
| 09.02. | Waters Completes Combination With BD Biosciences, Diagnostic Solutions Businesses | ||
| 09.02. | Bruker Introduces Label-Free Characterization Platform for Nanoscale Bioparticles | ||
| 09.02. | Bristol Myers Squibb 4Q Results | ||
| 09.02. | Innovent and Lilly's Seventh Collaboration Sets Model to Accelerate Pipeline Development | ||
| 09.02. | PharmaEssentia to Establish a Manufacturing Subsidiary in Puerto Rico | ||
| 09.02. | Fresenius Kabi, Phlow Partner to Onshore the Manufacture of Epinephrine Injection in the U.S. | ||
| 09.02. | Eurofins Viracor BioPharma Services Expands Service Portfolio | ||
| 06.02. | Samsung Biologics Product Carbon Footprint System Validated by Third Party | ||
| 06.02. | Lilly 4Q Results | ||
| 06.02. | Eisai, Henlius Strike Japan Commercialization Deal for PD-1 Antibody Serplulimab | ||
| 06.02. | FDA Grants Priority Review for Pfizer's HYMPAVZI | ||
| 05.02. | Pfizer 4Q Results | ||
| 05.02. | ADARx Pharmaceuticals Appoints Donald Fong as CMO | ||
| 05.02. | Sanofi 4Q Results | ||
| 05.02. | Braveheart Bio Promotes CSO, Names New SVP | ||
| 05.02. | AbbVie Submits Regulatory Applications for Rinvoq in Patients with Vitiligo | ||
| 04.02. | Novo Nordisk FY25 Results | ||
| 04.02. | OXB and BMS Expand Partnership With Lentiviral Vectors for CAR-T Programs | ||
| 04.02. | Merck 4Q Results | ||
| 04.02. | Biomica and Lishan Biotech Ink License Agreement for Microbiome-Based Cancer Therapeutic | ||
| 04.02. | HighRes, Opentrons to Launch First AI Agent-to-Agent Lab Workflow | ||
| 04.02. | Charles River Laboratories to Close Maryland Cell Therapy Site, Cut 20 Jobs | ||
| 04.02. | Thermo Fisher to Close Franklin, Mass. Site, Cut Up to 80 Jobs |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.